TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32318722

Group type: EXPERIMENTAL
Intervention: Home-based monitoring
Number of subjects: 260

Group type: COMPARATOR
Intervention: Hospital-based monitoring
Number of subjects: 260
Study: 34487008

Group type: EXPERIMENTAL
Intervention: Stabilization Exercises (SE)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional Exercises (CE)
Number of subjects: 37
Study: 32317213

Group type: EXPERIMENTAL
Intervention: Nurse-led delirium prevention protocol
Number of subjects: 0
Study: 36314861

Group type: EXPERIMENTAL
Intervention: Trained physician group
Number of subjects: 283

Group type: COMPARATOR
Intervention: Untrained physician group
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Both trained and untrained physician groups
Number of subjects: 283
Study: 33734289

Group type: COMPARATOR
Intervention: 4 cycles of mitomycin/vindesine/cisplatin plus thoracic radiotherapy (TRT) of 60 Gy
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: weekly irinotecan/carboplatin for 6 weeks plus TRT of 60 Gy followed by 2 courses of irinotecan/carboplatin consolidation
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: weekly paclitaxel/carboplatin for 6 weeks plus TRT of 60 Gy followed by 2 courses of paclitaxel/carboplatin consolidation
Number of subjects: 440
Study: 32776220

Group type: EXPERIMENTAL
Intervention: Three 10‐min bouts of exercise (ACC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Single 30‐min bout of exercise (CONT)
Number of subjects: 10
Study: 35667781

Group type: EXPERIMENTAL
Intervention: 99DOTS intervention
Number of subjects: 18
Study: 33382137

Group type: EXPERIMENTAL
Intervention: One-step SEMS placement
Number of subjects: 90

Group type: COMPARATOR
Intervention: Two-step SEMS placement
Number of subjects: 90
Study: 35988255

Group type: EXPERIMENTAL
Intervention: Jacobson's relaxation technique along with Bhastrika Pranayama
Number of subjects: 30

Group type: COMPARATOR
Intervention: Diaphragmatic breathing exercises and chest expansion exercises
Number of subjects: 30
Study: 33563767

Group type: EXPERIMENTAL
Intervention: Bilateral V3 block with ropivacaine 0.75% (block group, n=50)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo (placebo group, n=57)
Number of subjects: 107
Study: 36254912

Group type: EXPERIMENTAL
Intervention: Recombinant erythropoietin (500 IU/kg) administered one to three days before surgery
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no recombinant erythropoietin)
Number of subjects: 66
Study: 32851532

Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone mineral (DBBM) covered by a synthetic polylactic membrane (test group)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: DBBM plus a porcine natural collagen membrane (positive control)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Defect only covered by the synthetic membrane (negative control group)
Number of subjects: 8
Study: 32998759

Group type: EXPERIMENTAL
Intervention: SI-Bord screening instrument
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: SI-Bord score
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Cut-off score > 9 for SI-Bord
Number of subjects: 342
Study: 34376153

Group type: EXPERIMENTAL
Intervention: Low-dose sodium thiopental (5 mg/kg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-dose sodium thiopental (7 mg/kg)
Number of subjects: 80
Study: 32316660

Group type: EXPERIMENTAL
Intervention: Wheat challenge
Number of subjects: 26

Group type: COMPARATOR
Intervention: Rice challenge
Number of subjects: 26
Study: 36152018

Group type: EXPERIMENTAL
Intervention: Oral function intervention (EG) including oral exercise and preventive oral care, with a reminder phone call every 2 weeks
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Oral function intervention (EG)
Number of subjects: 114
Study: 35585836

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 32
Study: 34726788

Group type: EXPERIMENTAL
Intervention: Bevacizumab and chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neuropathic AEs trajectory
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-grade AE trajectory
Number of subjects: 0
Study: 35805687

Group type: EXPERIMENTAL
Intervention: Modified osteotome sinus floor elevation (OSFE) technique
Number of subjects: 30
Study: 34876195

Group type: EXPERIMENTAL
Intervention: Full-thickness skin graft technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional synthetic composite mesh
Number of subjects: 0
Study: 35821118

Group type: COMPARATOR
Intervention: Proximal femoral nail (PFN) alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Proximal femoral nail augmented with trochanteric buttress plate (PFN + TBP)
Number of subjects: 60
Study: 34939897

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3025

Group type: EXPERIMENTAL
Intervention: Oncogenic HPV types
Number of subjects: 3025
Study: 32905615

Group type: EXPERIMENTAL
Intervention: Metronidazole (MTZ) + Amoxicillin (AMX) + Scaling and Root Planing (SRP)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Scaling and Root Planing (SRP) only
Number of subjects: 25
Study: 32049833

Group type: EXPERIMENTAL
Intervention: VR-based rehabilitation
Number of subjects: 85

Group type: COMPARATOR
Intervention: Traditional rehabilitation
Number of subjects: 85
Study: 35442211

Group type: EXPERIMENTAL
Intervention: Deep Q-learning (DQL) treatment decisions
Number of subjects: 536
Study: 32938866

Group type: EXPERIMENTAL
Intervention: TR‐RPDs
Number of subjects: 24

Group type: COMPARATOR
Intervention: MC‐RPDs
Number of subjects: 24
Study: 32331052

Group type: EXPERIMENTAL
Intervention: Cariprazine 1.5-3 mg/d
Number of subjects: 1383

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1383
Study: 35690076

Group type: EXPERIMENTAL
Intervention: 12-week priming interval with homologous BNT162b2
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: 12-week priming interval with homologous ChAdOx1 nCoV-19
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: 12-week priming interval with heterologous BNT162b2-ChAdOx1 nCoV-19
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: 12-week priming interval with heterologous ChAdOx1 nCoV-19-BNT162b2
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: All 12-week interval groups
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: Homologous BNT162b2
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: All 12-week priming intervals
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: 12-week schedules for homologous BNT162b2 and ChAdOx1 nCoV-19-BNT162b2
Number of subjects: 730
Study: 33971289

Group type: EXPERIMENTAL
Intervention: β-blocker use
Number of subjects: 14434

Group type: COMPARATOR
Intervention: Nonuse of β-blockers (Control)
Number of subjects: 14434
Study: 32522811

Group type: EXPERIMENTAL
Intervention: Full intervention (mail plus phone calls)
Number of subjects: 2632

Group type: EXPERIMENTAL
Intervention: Mail only
Number of subjects: 2632

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2632
Study: 34648188

Group type: EXPERIMENTAL
Intervention: Transdiagnostic web-based skills training program with telehealth-delivered coaching
Number of subjects: 32
Study: 616636799

Group type: EXPERIMENTAL
Intervention: Targeted comments
Number of subjects: 289

Group type: COMPARATOR
Intervention: Rubric delivery method (electronic or paper)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Rubric viewing rates
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Overall performance over time
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Preference for rubric method
Number of subjects: 289
Study: 36114704

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 233

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 233
Study: 33754794

Group type: EXPERIMENTAL
Intervention: NT-proBNP levels ≤1000 pg/mL in obese patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NT-proBNP levels ≤1000 pg/mL in nonobese patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Obese patients
Number of subjects: 0
Study: 33026823

Group type: EXPERIMENTAL
Intervention: Atropine (15 mcg/kg) administered intravenously
Number of subjects: 8

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 8
Study: 33033996

Group type: EXPERIMENTAL
Intervention: BEAP (Enhanced Adherence Package)
Number of subjects: 454

Group type: COMPARATOR
Intervention: SOC (Standard of Care)
Number of subjects: 454
Study: 32091400

Group type: EXPERIMENTAL
Intervention: One-month P2Y12 inhibitor therapy
Number of subjects: 210

Group type: COMPARATOR
Intervention: Six-month P2Y12 inhibitor therapy
Number of subjects: 210
Study: 33865446

Group type: EXPERIMENTAL
Intervention: Lecanemab (10 mg/kg biweekly)
Number of subjects: 854

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 854
Study: 33587220

Group type: EXPERIMENTAL
Intervention: Self-rated health indicators
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Objective health measures
Number of subjects: 1519
Study: 33231534

Group type: EXPERIMENTAL
Intervention: Personalized ACT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Non-personalized ACT
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 60
Study: 34906125

Group type: EXPERIMENTAL
Intervention: Virtual-jaw group (Group V-J)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Jaw-virtual group (Group J-V)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Virtual reality group (Group V)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional jaw model group (Group J)
Number of subjects: 60
Study: 34581430

Group type: EXPERIMENTAL
Intervention: VASP-guided ticagrelor dosing
Number of subjects: 374

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 374
Study: 33836436

Group type: EXPERIMENTAL
Intervention: Trialogical contact-based intervention
Number of subjects: 1318
Study: 33704653

Group type: EXPERIMENTAL
Intervention: Needle insertion at epineurium
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Needle insertion at subepineurium
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Needle contact with nerve
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Needle penetration of nerve
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Needle insertion
Number of subjects: 6
Study: 32790539

Group type: EXPERIMENTAL
Intervention: Intranasal ketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34767246

Group type: EXPERIMENTAL
Intervention: Cognitive training program
Number of subjects: 106

Group type: COMPARATOR
Intervention: Conventional nursing intervention
Number of subjects: 106
Study: 33237551

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L questionnaire
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: Multivariate analysis
Number of subjects: 1020
Study: 35713975

Group type: EXPERIMENTAL
Intervention: Asymmetric sinusoidal oscillations (equal amplitude, differing velocities)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Symmetric sinusoidal oscillations
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Asymmetric condition
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Asymmetric stimulation
Number of subjects: 25
Study: 33443580

Group type: EXPERIMENTAL
Intervention: aIIV3
Number of subjects: 757

Group type: COMPARATOR
Intervention: HD-IIV3
Number of subjects: 757
Study: 36293912

Group type: EXPERIMENTAL
Intervention: Beer (350 mL)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Water (350 mL)
Number of subjects: 32
Study: 33541567

Group type: EXPERIMENTAL
Intervention: Concurrent training + Eurycoma longifolia
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control + Eurycoma longifolia
Number of subjects: 45

Group type: COMPARATOR
Intervention: Concurrent training + placebo
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control + placebo
Number of subjects: 45
Study: 35239723

Group type: COMPARATOR
Intervention: Text-based message (TM)
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Text-based message and personalised video story (TM+VS)
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Both groups (TM and TM+VS)
Number of subjects: 477
Study: 34480563

Group type: EXPERIMENTAL
Intervention: High-dose glucocorticoids (methylprednisolone 10 mg/kg)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Standard-dose glucocorticoids (dexamethasone 8 mg)
Number of subjects: 174
Study: 35230622

Group type: EXPERIMENTAL
Intervention: Direct‐to‐patient message through the EHR portal with HCV antibody lab order
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 1600
Study: 33245288

Group type: EXPERIMENTAL
Intervention: Healthy Minds Program (HMP) - Awareness + Connection
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Healthy Minds Program (HMP) - Awareness + Insight
Number of subjects: 343

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 343
Study: 35688328

Group type: EXPERIMENTAL
Intervention: Unilateral pedicle screw fixation (UPSF)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Bilateral pedicle screw fixation (BPSF)
Number of subjects: 48
Study: 33452448

Group type: EXPERIMENTAL
Intervention: Rituximab maintenance (RM)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Non-maintenance (NM)
Number of subjects: 138
Study: 32359745

Group type: EXPERIMENTAL
Intervention: Powdered Nigella sativa seeds
Number of subjects: 40
Study: 35085877

Group type: EXPERIMENTAL
Intervention: Oxycodone/acetaminophen (Oxy)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Acetaminophen (APAP)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Comparison of Oxy vs APAP
Number of subjects: 151
Study: 33684641

Group type: EXPERIMENTAL
Intervention: BHV-1 seropositive camels (detected by ELISA)
Number of subjects: 865

Group type: EXPERIMENTAL
Intervention: Herd seroprevalence
Number of subjects: 865

Group type: EXPERIMENTAL
Intervention: Risk factors for BHV-1 infection
Number of subjects: 865

Group type: EXPERIMENTAL
Intervention: Multivariate analysis of risk factors
Number of subjects: 865
Study: 35179251

Group type: EXPERIMENTAL
Intervention: Fostamatinib 150 mg BID orally
Number of subjects: 24
Study: 32585741

Group type: EXPERIMENTAL
Intervention: Combined treatment of pinprick therapy with super pulse fractional CO2 laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Super pulse fractional CO2 laser
Number of subjects: 20
Study: 32678787

Group type: EXPERIMENTAL
Intervention: BT + DRT
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: LCT
Number of subjects: 29

Group type: COMPARATOR
Intervention: Driving simulation task
Number of subjects: 29
Study: 35287831

Group type: EXPERIMENTAL
Intervention: Patient-centered education (two sessions of 45-60 minutes)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Usual education
Number of subjects: 104
Study: 32132512

Group type: EXPERIMENTAL
Intervention: Lactated Ringers (LR)
Number of subjects: 1581

Group type: COMPARATOR
Intervention: Normal Saline (NS)
Number of subjects: 1581
Study: 35728488

Group type: EXPERIMENTAL
Intervention: Vocalization maneuver during the second stage of labor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine humanized vaginal deliveries
Number of subjects: 0
Study: 35829935

Group type: EXPERIMENTAL
Intervention: Abemaciclib 150 mg and Tamoxifen 20 mg (A + T)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Abemaciclib 150 mg (A-150)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Abemaciclib 200 mg and prophylactic loperamide (A-200)
Number of subjects: 234
Study: 34152787

Group type: EXPERIMENTAL
Intervention: Resilience-promoting program
Number of subjects: 264

Group type: COMPARATOR
Intervention: Diabetes education control
Number of subjects: 264
Study: 33197225

Group type: EXPERIMENTAL
Intervention: Atezolizumab + bevacizumab (atezo + bev)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors (sorafenib or lenvatinib)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitor (second-line therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cabozantinib, regorafenib, ramucirumab, atezo + bev (second-line therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pembrolizumab or nivolumab (second-line therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nivolumab + ipilimumab (second-line and third-line therapy)
Number of subjects: 0
Study: 35942243

Group type: EXPERIMENTAL
Intervention: Yogurt with Job's tears (200 ml daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Yogurt alone (containing Lactobacillus acidophilus La5 and Bifidobacterium Bb12)
Number of subjects: 60
Study: 33247996

Group type: EXPERIMENTAL
Intervention: Depressed patients
Number of subjects: 400
Study: 33598767

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 30
Study: 32958203

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 69

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 69
Study: 35916505

Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (LTVV, Vt = 5 mL/kg along with 5 cm of H2O PEEP)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (LTVV)
Number of subjects: 28

Group type: COMPARATOR
Intervention: MCC950 (an inhibitor of NLRP3)
Number of subjects: 28

Group type: COMPARATOR
Intervention: High-tidal-volume ventilation (Vt = 10 mL/kg without PEEP)
Number of subjects: 28
Study: 34924001

Group type: EXPERIMENTAL
Intervention: Core Outcome Sets (COS)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Barriers to using COS
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Enablers to using COS
Number of subjects: 62
Study: 34676577

Group type: EXPERIMENTAL
Intervention: Fluoride varnish (FV)
Number of subjects: 513

Group type: COMPARATOR
Intervention: Control (CO)
Number of subjects: 513
Study: 32164792

Group type: EXPERIMENTAL
Intervention: LiuZiJue Qigong (LQG) combined with conventional rehabilitation therapy
Number of subjects: 160

Group type: COMPARATOR
Intervention: Traditional core stability training combined with conventional rehabilitation therapy
Number of subjects: 160
Study: 35621277

Group type: EXPERIMENTAL
Intervention: CMR-based surveillance
Number of subjects: 106
Study: 34169328

Group type: EXPERIMENTAL
Intervention: Home prehabilitation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 20
Study: 32711801

Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg
Number of subjects: 387

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 387
Study: 35417316

Group type: EXPERIMENTAL
Intervention: ROC training while sitting (ROC-Sit)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: ROC training while standing (ROC-Stand)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional therapy (control)
Number of subjects: 38
Study: 33430950

Group type: EXPERIMENTAL
Intervention: Navigate online decision aid
Number of subjects: 304

Group type: COMPARATOR
Intervention: Control arm (website of Australia’s peak national body for prostate cancer)
Number of subjects: 304
Study: 32912441

Group type: EXPERIMENTAL
Intervention: Complete revascularization in patients with QCA stenosis ≥60%
Number of subjects: 3851

Group type: COMPARATOR
Intervention: Control group in patients with QCA stenosis <60%
Number of subjects: 3851
Study: 34562781

Group type: EXPERIMENTAL
Intervention: Active Seat (BoseRide® electro‐magnetic active seat)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Passive Seat (new version of current passive air suspension seat)
Number of subjects: 276
Study: 33835597

Group type: EXPERIMENTAL
Intervention: Daily monetary incentives + self-monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed lump sum monetary incentives + self-monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-monitoring only
Number of subjects: 0
Study: 32811461

Group type: EXPERIMENTAL
Intervention: Substance P (SP)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: MCP-1
Number of subjects: 51
Study: 36124312

Group type: EXPERIMENTAL
Intervention: Exercise plus nutrition program (Ex + Nt group, n = 36)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Exercise program (Ex group, n = 36)
Number of subjects: 72
Study: 33021044

Group type: EXPERIMENTAL
Intervention: Vilaprisan (2 mg) after high-fat, high-calorie meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vilaprisan (2 mg) after moderate-fat, moderate-calorie meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Vilaprisan (2 mg) under fasting conditions
Number of subjects: 12
Study: 616636653

Group type: EXPERIMENTAL
Intervention: study‐test‐study (S‐T‐S) using a blocked order
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: study‐test‐study (S‐T‐S) using an interleaved order
Number of subjects: 0

Group type: COMPARATOR
Intervention: study‐study‐study (S‐S‐S) using a blocked order
Number of subjects: 0

Group type: COMPARATOR
Intervention: study‐study‐study (S‐S‐S) using an interleaved order
Number of subjects: 0
Study: 35156404

Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring Before Exposure (CR Before)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Cognitive Restructuring After Exposure (CR After)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both CR Before and CR After
Number of subjects: 93
Study: 33813753

Group type: EXPERIMENTAL
Intervention: Zoledronate (ZOL) administered 6 months after last denosumab
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Zoledronate (ZOL) administered 9 months after last denosumab
Number of subjects: 61

Group type: COMPARATOR
Intervention: Observation group (OBS)
Number of subjects: 61
Study: 32981695

Group type: EXPERIMENTAL
Intervention: Niraparib 300 mg once daily
Number of subjects: 367

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367
Study: 35863099

Group type: EXPERIMENTAL
Intervention: PENPal‐HF plus usual care
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study: 33761535

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (HBOT)
Number of subjects: 50
Study: 32739444

Group type: EXPERIMENTAL
Intervention: Self-assessment of cultural dexterity skills by residents
Number of subjects: 494

Group type: COMPARATOR
Intervention: Patient perception of culturally dexterous care
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Self-identification of residents' cultural dexterity
Number of subjects: 494

Group type: COMPARATOR
Intervention: Patient reports of culturally dexterous care by race
Number of subjects: 494